DrugDashboards

Javadin

clonidine hydrochloride oral · CLONIDINE HYDROCHLORIDE 20 ug/mL · Solution · Oral · Azurity Pharmaceuticals, Inc.

NDC 24338-0115-01 · 1 BOTTLE in 1 CARTON / 250 mL in 1 BOTTLE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00Jun 2026Sep 2026$1.53
3 price points · per MLSource: CMS NADAC

Estimated fill cost

Estimated WAC per mLestimate
$1.577
No Texas or California filing exists for this NDC — this figure is derived, not filed.

This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.

Medicaid spend (2026 YTD · Q1)

$172,807
538 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for clonidine hydrochloride (other) in the next 90 days

sole-source market · price up 4% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
NDA220256
TE code
Approval date
Oct 23, 2025
Patents / exclusivity
2 patents, 0 exclusivities
TypeNumber / codeExpires
patent12233049Jul 15, 2042
patent12440474Jul 15, 2042

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of clonidine hydrochloride oral (Solution)

LabelerStrengthFirst seenLast seen
Azurity Pharmaceuticals, Inc.CLONIDINE HYDROCHLORIDE 20 ug/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Javadin — NDC 24338-0115-01," retrieved September 3, 2026, https://drugdashboards.com/drug/24338011501.

Free to cite with attribution — see how the data is put together.